Literature DB >> 1312376

Tamoxifen retinopathy: a rare but serious complication.

C R Bentley1, G Davies, W A Aclimandos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1312376      PMCID： PMC1881086          DOI： 10.1136/bmj.304.6825.495

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Tamoxifen retinopathy at low dosage.

Authors:  M F Griffiths
Journal:  Am J Ophthalmol       Date:  1987-08-15       Impact factor: 5.258

2.  Ocular toxicity of tamoxifen.

Authors:  E W Gerner
Journal:  Ann Ophthalmol       Date:  1989-11

3.  Tamoxifen retinopathy. A clinicopathologic report.

Authors:  M I Kaiser-Kupfer; C Kupfer; M M Rodrigues
Journal:  Ophthalmology       Date:  1981-01       Impact factor: 12.079

Review 4.  Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

5.  Retinopathy caused by treatment with tamoxifen in low dosage.

Authors:  T Vinding; N V Nielsen
Journal:  Acta Ophthalmol (Copenh)       Date:  1983-02

6.  Tamoxifen retinopathy.

Authors:  M I Kaiser-Kupfer; M E Lippman
Journal:  Cancer Treat Rep       Date:  1978-03

7.  Tamoxifen retinopathy.

Authors:  C A McKeown; M Swartz; J Blom; J M Maggiano
Journal:  Br J Ophthalmol       Date:  1981-03       Impact factor: 4.638
  7 in total
  8 in total

1.  [Unusual symptoms for tamoxifen-associated maculopathy].

Authors:  T Hager; S Hoffmann; B Seitz
Journal:  Ophthalmologe       Date:  2010-08       Impact factor: 1.059

2.  Adjuvant treatment with tamoxifen. Clinicians must share knowledge with their patients more readily.

Authors:  H Goodare
Journal:  BMJ       Date:  1996-04-20

3.  [Tamoxifen retinopathy: a case series of clinical and functional data].

Authors:  C Ritter; A B Renner; J Wachtlin; N E Bechrakis; L Krause
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

4.  Phase I trial of droloxifene in patients with metastatic breast cancer.

Authors:  A U Buzdar; S Kau; G N Hortobagyi; R L Theriault; D Booser; F A Holmes; R Walters; I H Krakoff
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Retinal function in patients treated with tamoxifen.

Authors:  Sung Eun Song Watanabe; Adriana Berezovsky; Márcia Motono; Paula Yuri Sacai; Josenilson Martins Pereira; Juliana Maria Ferraz Sallum; Luiz Henrique Gebrim; Solange Rios Salomão
Journal:  Doc Ophthalmol       Date:  2010-04       Impact factor: 2.379

Review 6.  Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.

Authors:  V C Jordan
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

7.  The goldfish as a model for studying neuroestrogen synthesis, localization, and action in the brain and visual system.

Authors:  G V Callard; A Kruger; M Betka
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

8.  Imaging tamoxifen retinopathy using spectral-domain optical coherence tomography.

Authors:  Albert Caramoy; Paula Scholz; Sascha Fauser; Bernd Kirchhof
Journal:  GMS Ophthalmol Cases       Date:  2011-12-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.